Your browser doesn't support javascript.
loading
Falls Predict Acute Hospitalization in Parkinson's Disease.
Santos García, Diego; de Deus Fonticoba, Teresa; Cores, Carlos; Suárez Castro, Ester; Hernández Vara, Jorge; Jesús, Silvia; Mir, Pablo; Cosgaya, Marina; José Martí, Maria; Pastor, Pau; Cabo, Iria; Seijo, Manuel; Legarda, Inés; Vives, Bárbara; Caballol, Nuria; Rúiz Martínez, Javier; Croitoru, Ioana; Cubo, Esther; Miranda, Javier; Alonso Losada, Maria Gema; Labandeira, Carmen; López Ariztegui, Nuria; Morales-Casado, Mabel; González Aramburu, Isabel; Infante, Jon; Escalante, Sonia; Bernardo, Noemí; Blázquez Estrada, Marta; Menéndez González, Manuel; García Caldentey, Juan; Borrué, Carmen; Vela, Lydia; Catalán, Maria José; Gómez Mayordomo, Víctor; Kurtis, Mónica; Prieto, Cristina; Ordás, Carlos; Nogueira, Víctor; López Manzanares, Lydia; Ávila Rivera, Maria Asunción; Puente, Victor; García Moreno, Jose Manuel; Solano Vila, Berta; Álvarez Sauco, María; Carrillo Padilla, Francisco; Martínez Castrillo, Juan Carlos; Sánchez Alonso, Pilar; Gastón, Itziar; Kulisevsky, Jaime; Valero, Caridad.
Affiliation
  • Santos García D; CHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
  • de Deus Fonticoba T; CHUF, Complejo Hospitalario Universitario de Ferrol, A Coruña, Spain.
  • Cores C; CHUAC, Complejo Hospitalario Universitario de A Coruña, A Coruña, Spain.
  • Suárez Castro E; CHUF, Complejo Hospitalario Universitario de Ferrol, A Coruña, Spain.
  • Hernández Vara J; Neurology Department and Neurodegenerative Diseases Research. Vall D'Hebron Universitary Campus, Barcelona, Spain.
  • Jesús S; Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.
  • Mir P; CIBERNED (Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas), Spain.
  • Cosgaya M; Unidad de Trastornos del Movimiento, Servicio de Neurología y Neurofisiología Clínica, Instituto de Biomedicina de Sevilla, Hospital Universitario Virgen del Rocío/CSIC/Universidad de Sevilla, Seville, Spain.
  • José Martí M; CIBERNED (Centro de Investigación Biomédica en Red Enfermedades Neurodegenerativas), Spain.
  • Pastor P; Hospital Clínic de Barcelona, Barcelona, Spain.
  • Cabo I; Hospital Clínic de Barcelona, Barcelona, Spain.
  • Seijo M; Movement disorders Unit, University Hospital Mutua de Terrassa, Barcelona, Spain.
  • Legarda I; Complejo Hospitalario Universitario de Pontevedra (CHOP), Pontevedra, Spain.
  • Vives B; Complejo Hospitalario Universitario de Pontevedra (CHOP), Pontevedra, Spain.
  • Caballol N; Hospital Universitario Son Espases, Palma de Mallorca, Spain.
  • Rúiz Martínez J; Hospital Universitario Son Espases, Palma de Mallorca, Spain.
  • Croitoru I; Consorci Sanitari Integral, Hospital Moisés Broggi, Sant Joan Despí, Barcelona, Spain.
  • Cubo E; Hospital Universitario Donostia, San Sebastián, Spain.
  • Miranda J; Hospital Universitario Donostia, San Sebastián, Spain.
  • Alonso Losada MG; Complejo Asistencial Universitario de Burgos, Burgos, Spain.
  • Labandeira C; Complejo Asistencial Universitario de Burgos, Burgos, Spain.
  • López Ariztegui N; Hospital Álvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo (CHUVI), Vigo, Spain.
  • Morales-Casado M; Hospital Álvaro Cunqueiro, Complejo Hospitalario Universitario de Vigo (CHUVI), Vigo, Spain.
  • González Aramburu I; Complejo Hospitalario de Toledo, Toledo, Spain.
  • Infante J; Complejo Hospitalario de Toledo, Toledo, Spain.
  • Escalante S; Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Bernardo N; Hospital Universitario Marqués de Valdecilla, Santander, Spain.
  • Blázquez Estrada M; Hospital de Tortosa Verge de la Cinta (HTVC), Tortosa, Tarragona, Spain.
  • Menéndez González M; Hospital de Tortosa Verge de la Cinta (HTVC), Tortosa, Tarragona, Spain.
  • García Caldentey J; Hospital Universitario Central de Asturias, Oviedo, Spain.
  • Borrué C; Movement disorders Unit, University Hospital Mutua de Terrassa, Barcelona, Spain.
  • Vela L; Centro Neurológico Oms, Palma de Mallorca, Spain.
  • Catalán MJ; Hospital Infanta Sofía, Madrid, Spain.
  • Gómez Mayordomo V; Fundación Hospital de Alcorcón, Madrid, Spain.
  • Kurtis M; Hospital Universitario Clínico San Carlos, Madrid, Spain.
  • Prieto C; Hospital Universitario Clínico San Carlos, Madrid, Spain.
  • Ordás C; Hospital Ruber Internacional, Madrid, Spain.
  • Nogueira V; Hospital Rey Juan Carlos, Madrid, Spain.
  • López Manzanares L; Hospital Rey Juan Carlos, Madrid, Spain.
  • Ávila Rivera MA; Hospital Da Costa, Burela, Lugo, Spain.
  • Puente V; Hospital Universitario La Princesa, Madrid, Spain.
  • García Moreno JM; Consorci Sanitari Integral, Hospital General de L'Hospitalet, L'Hospitalet de Llobregat, Barcelona, Spain.
  • Solano Vila B; Hospital del Mar, Barcelona, Spain.
  • Álvarez Sauco M; Hospital Universitario Virgen Macarena, Sevilla, Spain.
  • Carrillo Padilla F; Institut d'Assistència Sanitària (IAS) - Institut Català de la Salut. Girona, Spain.
  • Martínez Castrillo JC; Hospital General Universitario de Elche, Elche, Spain.
  • Sánchez Alonso P; Hospital Universitario de Canarias, San Cristóbal de la Laguna, Santa Cruz de Tenerife, Spain.
  • Gastón I; Hospital Universitario Ramón y Cajal, Madrid, Spain.
  • Kulisevsky J; Hospital Universitario Puerta de Hierro, Madrid, Spain.
  • Valero C; Complejo Hospitalario de Navarra, Pamplona, Spain.
J Parkinsons Dis ; 13(1): 105-124, 2023.
Article de En | MEDLINE | ID: mdl-33843696
ABSTRACT

BACKGROUND:

There is a need for identifying risk factors for hospitalization in Parkinson's disease (PD) and also interventions to reduce acute hospital admission.

OBJECTIVE:

To analyze the frequency, causes, and predictors of acute hospitalization (AH) in PD patients from a Spanish cohort.

METHODS:

PD patients recruited from 35 centers of Spain from the COPPADIS-2015 (COhort of Patients with PArkinson's DIsease in Spain, 2015) cohort from January 2016 to November 2017, were included in the study. In order to identify predictors of AH, Kaplan-Meier estimates of factors considered as potential predictors were obtained and Cox regression performed on time to hospital encounter 1-year after the baseline visit.

RESULTS:

Thirty-five out of 605 (5.8%) PD patients (62.5±8.9 years old; 59.8% males) presented an AH during the 1-year follow-up after the baseline visit. Traumatic falls represented the most frequent cause of admission, being 23.7% of all acute hospitalizations. To suffer from motor fluctuations (HR [hazard ratio] 2.461; 95% CI, 1.065-5.678; p = 0.035), a very severe non-motor symptoms burden (HR [hazard ratio] 2.828; 95% CI, 1.319-6.063; p = 0.008), falls (HR 3.966; 95% CI 1.757-8.470; p = 0.001), and dysphagia (HR 2.356; 95% CI 1.124-4.941; p = 0.023) was associated with AH after adjustment to age, gender, disease duration, levodopa equivalent daily dose, total number of non-antiparkinsonian drugs, and UPDRS-IIIOFF. Of the previous variables, only falls (HR 2.998; 95% CI 1.080-8.322; p = 0.035) was an independent predictor of AH.

CONCLUSION:

Falls is an independent predictor of AH in PD patients.
Sujet(s)

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie de Parkinson Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: J Parkinsons Dis Année: 2023 Type de document: Article Pays d'affiliation: Espagne

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Maladie de Parkinson Type d'étude: Prognostic_studies / Risk_factors_studies Limites: Aged / Female / Humans / Male / Middle aged Pays/Région comme sujet: Europa Langue: En Journal: J Parkinsons Dis Année: 2023 Type de document: Article Pays d'affiliation: Espagne
...